Clough Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Clough Capital Partners's MRK Position: Q3 2024 in Review
Clough Capital Partners sold out of Merck (MRK) in Q3 2024, closing a stake of 129,503 shares — an estimated $16M sold.
Clough Capital Partners first reported a position in MRK in Q2 2013 and held it in 18 quarters. The position peaked at $29.3M in Q3 2013. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.
- Clough Capital Partners reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
- Clough Capital Partners sold 129,503 Merck shares in Q3 2024, an estimated $16M.
- Clough Capital Partners first reported a position in Merck in Q2 2013 and held it in 18 quarters.
- Clough Capital Partners's Merck position peaked at $29.3M in Q3 2013.
- 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.
Based on Clough Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.